Activated Pancreatic Stellate Cells Sequester CD8+ T Cells to Reduce Their Infiltration of the Juxtatumoral Compartment of Pancreatic Ductal Adenocarcinoma-Reference-Cited by-同舟云学术

Activated Pancreatic Stellate Cells Sequester CD8+ T Cells to Reduce Their Infiltration of the Juxtatumoral Compartment of Pancreatic Ductal Adenocarcinoma

Published:2013-11 Issue:5 Volume:145 Page:1121-1132
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Ene–Obong Abasi,Clear Andrew J.,Watt Jennifer,Wang Jun,Fatah Rewas,Riches John C.,Marshall John F.,Chin–Aleong Joanne,Chelala Claude,Gribben John G.,Ramsay Alan G.,Kocher Hemant M.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference38 articles.

1. What we have learned about pancreatic cancer from mouse models;Perez-Mancera;Gastroenterology,2012

2. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion;Schreiber;Science,2011

3. Natural innate and adaptive immunity to cancer;Vesely;Annu Rev Immunol,2011

4. Adoptive immunotherapy for cancer: harnessing the T cell response;Restifo;Nat Rev Immunol,2012

5. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting;Matsushita;Nature,2011

Cited by 445 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutrophils as promising therapeutic targets in pancreatic cancer liver metastasis;International Immunopharmacology;2024-10

2. The Role of Tumor Microenvironment in Pancreatic Cancer Immunotherapy: Current Status and Future Perspectives;International Journal of Molecular Sciences;2024-09-03

3. Enhancing pancreatic cancer immunotherapy: Leveraging localized delivery strategies through the use of implantable devices and scaffolds;Journal of Controlled Release;2024-09

4. Efficacy and safety of gemcitabine/nab-paclitaxel combined with anlotinib and PD-1 inhibitors as a first-line treatment for advanced pancreatic cancer;International Immunopharmacology;2024-09

5. Epigenetic regulation of the tumor microenvironment: A leading force driving pancreatic cancer;Pancreatology;2024-09